By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


3SBio Inc. 

3 A1, Road 10
Economy & Technology Development Zone
Shenyang    110027  China
Phone: 86-24-2581-1820 Fax:


Company News
3SBio Inc. (SSRX) Obtains Exclusive Licenses To Develop And Market Jenkem's PEG-Irinotecan In China 9/17/2014 8:10:42 AM
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement With DinoNa For Leukotuximab 8/8/2014 8:24:24 AM
3SBio Inc. (SSRX) Exclusively Licenses Pegsiticase (Uricase PEG-20) To Selecta Biosciences, Inc. To Develop Drug Candidate To Treat Gout 6/18/2014 9:20:48 AM
Selecta Biosciences, Inc. Enters Into Exclusive License Agreement With 3SBio Inc. (SSRX) To Develop Drug Candidate To Treat Gout 6/17/2014 11:29:08 AM
3SBio Inc. (SSRX) to Develop DJ5 for Progressive Renal Failure in ADPKD Patients 10/29/2013 10:29:55 AM
3SBio Inc. (SSRX) Announces Completion of Merger 5/30/2013 10:29:58 AM
3SBio Inc. (SSRX) Announces Shareholders' Approval of the Amended Merger Agreement 5/28/2013 8:59:46 AM
3SBio Inc. (SSRX)'s Shareholders Approve Go-Private Transaction 5/24/2013 12:33:13 PM
3SBio Inc. (SSRX) Schedules Take-Private Vote for May 24 5/3/2013 9:51:02 AM
3SBio Inc. (SSRX) Files Annual Report on Form 20-F for Fiscal Year 2012 5/2/2013 2:43:20 PM